Citations

1. Parker SK, et al. (2004). Thimerosal-containing vaccines and autistic spectrum disorder: A critical review of published original data. Pediatrics 114(3): 793–804.

2. U.S. Food and Drug Administration (2006). Thimerosal content in some currently manufactured U.S. licensed vaccines. Available online: http://www.fda.gov/cber/vaccine/thimerosal.htm#t3.

3. Demicheli V, et al. (2007). Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

4. Centers for Disease Control and Prevention (2008). Recommended immunization schedules for persons aged 0–18 years-United States, 2008. MMWR, 57(01): Q1–Q4. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a8.htm. [Erratum in MMWR, 57(12): 319. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5712a6.htm.]

5. Centers for Disease Control and Prevention (2005). Notice to readers: Licensure of a combined live attenuated measles, mumps, rubella, and varicella vaccine. MMWR, 54(47): 1212–1214. Also available online: http://www.cdc.gov/mmwr/PDF/wk/mm5447.pdf. [Erratum in MMWR, 54(48): 1237. Also available online: http://www.cdc.gov/mmwr/pdf/wk/mm5448.pdf.]

6. Centers for Disease Control and Prevention (2007). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR-6): 1–60. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5606.pdf.

7. Atkinson W, et al., eds. (2007). Epidemiology and Prevention of Vaccine-Preventable Diseases, updated 10th ed. (The Pink Book). Washington, DC: Public Health Foundation. Also available online: http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm.

8. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR–2): 1–24. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5602.pdf.

9. Saslow D, et al. (2007). American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA: A Cancer Journal for Clinicians, 57(1): 7–28.

10. Centers for Disease Control and Prevention (1998, updated 2007). Guidelines for Vaccinating Pregnant Women From Recommendations of the Advisory Committee on Immunization Practices (ACIP). Available online: http://www.cdc.gov/vaccines/pubs/preg-guide.htm.

11. U.S. Food and Drug Administration (2007). FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. FDA News. Available online: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01611.html.

12. Mitka M (2007). Bioterror vaccine production: Take 2. JAMA, 297(6): 575–576.

13. Breman JG, Henderson DA (2002). Diagnosis and management of smallpox. New England Journal of Medicine, 346(17): 1300–1308.

14. Centers for Disease Control and Prevention (2006). Smallpox fact sheet: Vaccine overview. Available online: http://www.bt.cdc.gov/agent/smallpox/vaccination/facts.asp.

Other Works Consulted

• Centers for Disease Control and Prevention (2007). Mercury and vaccines (Thimerosal). Available online: http://www.cdc.gov/vaccinesafety/concerns/thimerosal.htm.

• American Academy of Pediatrics (2007). Hepatitis A vaccine recommendations. Pediatrics, 120(1): 189–199. Also available online: http://aappolicy.aappublications.org/cgi/reprint/pediatrics;120/1/189.pdf.

• Centers for Disease Control and Prevention (1998). Measles, mumps, and rubella-Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 47(RR-8): 1–59. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr4708.pdf.

• Centers for Disease Control and Prevention (2005). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of infants, children, and adolescents. MMWR, 54(RR-16): 1–23. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm. [Erratum in MMWR, 55(06): 158–159. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5506a6.htm.]

• Centers for Disease Control and Prevention (2006). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. MMWR, 55(RR-16): 1–33. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a1.htm. [Erratum in MMWR, 56(42): 1114.]

• Centers for Disease Control and Prevention (2006). Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55 (RR-7): 1–23. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5507.pdf.

• Centers for Disease Control and Prevention (2006). Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55(RR-3): 1–44. Also available online: http://www.cdc.gov/mmwr/PDF/RR/RR5503.pdf.

• Centers for Disease Control and Prevention (2006). Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee, for Use of Tdap Among Health-Care Personnel. MMWR, 55(RR-17): 1–37. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5517.pdf.

• Centers for Disease Control and Prevention (2007). Notice to readers: Expansion of use of live attenuated influenza vaccine (FluMist®) to children aged 2–4 years and other FluMist changes for the 2007–08 influenza season. MMWR, 56(46): 1217–1219. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5646a4.htm?s_cid=mm5646a4_e.

• Centers for Disease Control and Prevention (2007). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR-4): 1–48. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5604.pdf.

• Centers for Disease Control and Prevention (2007). Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR, 56(31): 794–795. Also available online: http://www.cdc.gov/mmwr/PDF/wk/mm5631.pdf.

• Centers for Disease Control and Prevention (2008). Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 57(Early Release): 1–30. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr57e0515.pdf.

• Centers for Disease Control and Prevention (2008). Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 57: 1–51. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr57e0514.pdf.

• Centers for Disease Control and Prevention (2008). Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24–59 months who are not completely vaccinated. MMWR, 57(13): 343–344. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5713a4.htm?s_cid=mm5713a4_e.

• Centers for Disease Control and Prevention (1997). Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 46(RR-8): 1–25.

• Committee on Infectious Disease, American Academy of Pediatrics (1999). Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization. Pediatrics, 104(6): 1404–1406.

• Committee on Infectious Diseases, American Academy of Pediatrics (2000). Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics, 106(2): 362–366.

• Dear KB G, et al. (2007). Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews (2).

• Orenstein WA, Pickering LK (2007). Immunization practices. In RM Kliegman et al., eds., Nelson Textbook of Pediatrics, 18th ed., pp. 1058–1070. Philadelphia: Saunders Elsevier.

• Pneumococcal vaccine (Prevnar) for otitis media (2003). Medical Letter on Drugs and Therapeutics, 45 (W1153B): 27–28.

• Thompson WW, et al. (2007). Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. New England Journal of Medicine, 357(13): 1281–1292.

• U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2006). General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55(RR-15): 1–48. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5515.pdf. [Erratum in MMWR, 56(11): 256. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5611a6.htm?s_cid=mm5611a6_e.]

• Weller PF (2005). Health advice for international travelers. In DC Dale, DD Federman, eds., ACP Medicine, Clinical Essentials, chap. 7. New York: WebMD.